ASCENDIS PHARMA A/S - ADR (ASND)

US04351P1012 - ADR

131.57  -2.47 (-1.84%)

Premarket: 134 +2.43 (+1.85%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
327.43M266.72M51.17M7.78M6.95M
Cost Of Goods
49.69M44.40M12.14M3.52MN/A
Gross Profit
277.74M222.32M39.04M4.26MN/A
Operating Expenses
593.49M670.03M600.85M456.05M337.57M
Research and Development
311.66M395.32M368.73M285.77M248.71M
Selling, General, and Administrative Expenses
269.74M258.30M215.85M155.59M72.56M
Operating Income
-315.76M-447.71M-561.81M-451.79M-330.62M
Interest Income/Expense
-101.19M-18.60M-11.68M67.85M-88.55M
Other Income/Expense
N/A0.00-4.32MN/AN/A
Non Recurring Items
N/A-7.83MN/AN/AN/A
Income Before Taxes
-416.94M-474.14M-577.82M-383.94M-419.17M
Income Tax
9.55M7.30M5.38M-370.00K-220.00K
Net Income
-426.49M-481.45M-583.19M-383.58M-418.96M
EBITDA
-297.54M-428.80M-543.86M-436.39M-321.17M
 
Per Share Data
EPS Diluted Total Ops
-7.19-8.23-10.00-6.73-7.97
Non GAAP EPS
-7.47-8.56-10.40-7.01-8.24
 
Statistics
Gross Profit Margin
84.82%83.36%76.29%54.76%N/A
Profit Margin
-130.26%-180.51%-1139.71%-4930.33%-6028.20%
Operating Profit Margin
-96.44%-167.86%-1097.93%-5807.07%-4757.12%

All data in EUR

Charts